フェニレフリン医薬品の世界市場レポート2025年

フェニレフリン医薬品市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.9％で、408億3,000万米ドルに成長します。この将来的な成長の要因としては、発展途上国におけるヘルスケア支出の拡大、クリティカルケア環境における低血圧治療への応用拡大、高齢化人口の増加、鼻腔ケアに関する社会的認知度の向上、併用療法オプションの幅広い採用などが挙げられます。予測期間中に予想される顕著な動向には、鼻腔デリバリー技術の革新、薬剤製剤の安定性の向上、鼻腔スプレー技術の進歩、薬剤とデバイスの組み合わせの統合、市販薬使用のためのデジタル監視ソリューションなどがあります。

呼吸器疾患の罹患率の上昇が、今後数年間のフェニレフリン医薬品市場の成長を促進すると予想されます。呼吸器疾患とは、呼吸に関与する肺や気道を含む呼吸器系に影響を及ぼすあらゆる状態を指します。これらの疾患の増加に大きく寄与しているのは大気汚染であり、大気汚染は肺組織を損傷し、呼吸機能を損ない、喘息などの病気を誘発します。フェニレフリン医薬品は、鼻の充血除去剤として作用し、呼吸器疾患の症状を緩和します。鼻腔の血管を収縮させ、腫れを抑え、空気の流れを良くすることで、風邪、アレルギー、副鼻腔感染症に伴う鼻づまり、副鼻腔の圧迫感、呼吸困難などの症状を緩和します。例えば、2023年11月、オーストラリアを拠点とする非営利団体National Asthma Councilは、2022年にオーストラリアで467人の喘息関連死（うち女性299人、男性168人）が記録され、2021年の355人から増加したと報告しました。このように、呼吸器疾患の発生率の増加は、フェニレフリン医薬品市場の成長に大きく寄与しています。

フェニレフリン医薬品市場で事業を展開する主要企業は、利便性の向上、調製時間の短縮、患者の安全性向上のため、Ready-to-useバイアルなどの革新的な製剤に注力しています。Ready-to-useバイアルには、あらかじめ混合され、計量された薬液が含まれており、すぐに投与できるため、希釈や調製の必要がありません。これらのバイアルは、投与ミスを減らし、緊急時の薬剤投与を迅速化し、一貫した薬剤の効能と無菌性を確保するのに役立ちます。例えば、2023年12月、ジェネリック注射剤および経口剤の製造で知られる英国の製薬会社Hikma Pharmaceuticals PLCは、すぐに使用できるフェニレフリン塩酸塩注射剤USPをIMMPHENTIVの商品名で米国で発売しました。この製品は500mcg/5mLと1,000mcg/10mLのバイアルがあり、米国で初めてFDAが承認した1,000mcg/10mL製剤です。この製品は、麻酔中の血管拡張により臨床的に重大な低血圧を経験している成人の血圧を上昇させることを目的としており、投薬ミスを減らし患者の安全をサポートする標準化された希釈済みオプションを病院に提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のフェニレフリン医薬品：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のフェニレフリン医薬品市場：成長率分析
• 世界のフェニレフリン医薬品市場の実績：規模と成長, 2019-2024
• 世界のフェニレフリン医薬品市場の予測：規模と成長, 2024-2029, 2034F
• 世界のフェニレフリン医薬品：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のフェニレフリン医薬品市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• シロップ
• 目薬
• その他の製品タイプ
• 世界のフェニレフリン医薬品市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 寒い
• 鼻づまりの解消
• アレルギー反応
• 眼疾患
• その他の適応症
• 世界のフェニレフリン医薬品市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• その他の投与経路
• 世界のフェニレフリン医薬品市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• ドラッグストアと薬局
• オンライン薬局
• 世界のフェニレフリン医薬品市場錠剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 即放錠
• 徐放錠
• 配合錠
• 口腔内崩壊錠
• 世界のフェニレフリン医薬品市場シロップの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児用シロップ
• 大人用シロップ
• 無糖シロップ
• 世界のフェニレフリン医薬品市場点眼薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 処方箋目薬
• 市販の目薬
• 混合点眼薬
• 使い捨て目薬
• 世界のフェニレフリン医薬品市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鼻スプレー
• 注射液
• 局所用ジェルまたはクリーム
• 坐薬

第7章 地域別・国別分析

• 世界のフェニレフリン医薬品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のフェニレフリン医薬品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• フェニレフリン医薬品市場：競合情勢
• フェニレフリン医薬品市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Procter And Gamble Co. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson And Johnson Consumer Inc Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sandoz Group AG
• Hikma Pharmaceuticals USA
• Siegfried AG
• Perrigo Company PLC
• Amneal Pharmaceuticals LLC
• Civica
• Xellia Pharmaceuticals USA LLC
• Camber Pharmaceuticals
• Exela Pharma Sciences
• Eton Pharmaceuticals
• SOLA Pharmaceuticals
• Fresenius Kabi USA
• Somerset Therapeutics
• Meitheal Pharmaceuticals
• Novadoz Pharmaceuticals LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• フェニレフリン医薬品市場2029：新たな機会を提供する国
• フェニレフリン医薬品市場2029：新たな機会を提供するセグメント
• フェニレフリン医薬品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Phenylephrine drugs are formulations that include phenylephrine, a synthetic sympathomimetic amine widely utilized as a decongestant, vasopressor, and mydriatic agent. It acts by stimulating alpha-1 adrenergic receptors, resulting in vasoconstriction (narrowing of blood vessels), which helps reduce nasal swelling, raise blood pressure, or dilate pupils, depending on how the drug is administered and its intended therapeutic purpose.

Phenylephrine drug products are primarily available in forms such as tablets, syrups, eye drops, and others. Tablets, being solid and portable dosage forms, offer accurate dosing and ease of consumption. They are commonly used to treat conditions like colds, nasal congestion, allergic reactions, eye disorders, and more. These medications can be taken orally or via parenteral routes and are distributed through a range of channels including hospital pharmacies, retail drugstores, and online platforms.

The phenylephrine drugs market research report is one of a series of new reports from The Business Research Company that provides phenylephrine drugs market statistics, including phenylephrine drugs industry global market size, regional shares, competitors with an phenylephrine drugs market share, detailed phenylephrine drugs market segments, market trends and opportunities, and any further data you may need to thrive in the phenylephrine drugs industry. The phenylephrine drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The phenylephrine drugs market size has grown rapidly in recent years. It will grow from $25.44 billion in 2024 to $28.03 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. Key drivers of this historical growth include the increased incidence of cold and flu, a surge in allergic rhinitis cases, a rising preference for over-the-counter treatment options, the expanding trend of self-medication, and a higher volume of surgical interventions.

The phenylephrine drugs market size is expected to see strong growth in the next few years. It will grow to $40.83 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. Factors contributing to this future growth include greater healthcare spending in developing nations, expanded application in treating hypotension in critical care settings, a growing aging population, enhanced public awareness regarding nasal care, and wider adoption of combination therapy options. Prominent trends anticipated in the forecast period include innovations in nasal delivery technologies, enhancements in drug formulation stability, progress in nasal spray technologies, integration of drug-device combinations, and digital monitoring solutions for over-the-counter drug usage.

The rising incidence of respiratory diseases is expected to drive the growth of the phenylephrine drugs market in the coming years. Respiratory diseases refer to any conditions that affect the respiratory system, including the lungs and airways involved in breathing. A significant contributor to the increase in these diseases is air pollution, which damages lung tissue, impairs respiratory function, and triggers illnesses such as asthma. Phenylephrine drugs alleviate symptoms of respiratory diseases by acting as nasal decongestants. They constrict blood vessels in the nasal passages, which reduces swelling and enhances airflow, thereby relieving symptoms like nasal congestion, sinus pressure, and breathing difficulties associated with colds, allergies, and sinus infections. For example, in November 2023, the National Asthma Council, an Australia-based non-profit organization, reported that in 2022, Australia recorded 467 asthma-related deaths, including 299 females and 168 males, an increase from 355 deaths in 2021. Thus, the increasing incidence of respiratory diseases contributes significantly to the growth of the phenylephrine drugs market.

Major companies operating in the phenylephrine drugs market are focusing on innovative formulations, such as ready-to-use vials, to improve convenience, reduce preparation time, and enhance patient safety. Ready-to-use vials contain pre-mixed, pre-measured drug solutions that are immediately ready for administration, eliminating the need for further dilution or preparation. These vials help reduce dosing errors, speed up drug administration in emergency settings, and ensure consistent drug potency and sterility. For instance, in December 2023, Hikma Pharmaceuticals PLC, a UK-based pharmaceutical company known for manufacturing generic injectable and oral formulations, launched its ready-to-use Phenylephrine HCl Injection, USP, in the U.S. under the brand name IMMPHENTIV. This product is available in 500 mcg/5 mL and 1,000 mcg/10 mL vials and is the first FDA-approved 1,000 mcg/10 mL formulation in the U.S. It is intended to raise blood pressure in adults experiencing clinically significant hypotension due to vasodilation during anesthesia, offering hospitals a standardized, pre-diluted option to reduce medication errors and support patient safety.

In June 2022, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical company, acquired generic injectable products from Eton Pharmaceuticals Inc. for an undisclosed sum. The acquisition was aimed at expanding and strengthening Dr. Reddy's institutional business in the U.S. by adding affordable injectable medications with limited competition that address critical care needs. This move enhances patient access to essential products. Eton Pharmaceuticals Inc., a U.S.-based pharmaceutical company, specializes in the development and commercialization of phenylephrine-based medications.

Major players in the phenylephrine drugs market are Pfizer Inc., Procter And Gamble Co., Johnson And Johnson Consumer Inc, Bayer AG, GlaxoSmithKline PLC, Sandoz Group AG, Hikma Pharmaceuticals USA, Siegfried AG, Perrigo Company PLC, Amneal Pharmaceuticals LLC, Civica, Xellia Pharmaceuticals USA LLC, Camber Pharmaceuticals, Exela Pharma Sciences, Eton Pharmaceuticals, SOLA Pharmaceuticals, Fresenius Kabi USA, Somerset Therapeutics, Meitheal Pharmaceuticals, Novadoz Pharmaceuticals LLC

North America was the largest region in the phenylephrine drugs market in 2024. The regions covered in phenylephrine drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the phenylephrine drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The phenylephrine drugs market consists of sales of oral decongestant tablets, sudafed PE, neo-synephrine, and phenylephrine HCl injection. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Phenylephrine Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on phenylephrine drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for phenylephrine drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The phenylephrine drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Tablets; Syrups; Eye Drops; Other Product Types
• 2) By Indication: Cold; Nasal Decongestion; Allergic Reaction; Eye Disease; Other Indications
• 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
• 4) By Distribution Channel: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Tablets: Immediate Release Tablets; Extended Release Tablets; Combination Tablets; Orally Disintegrating Tablets
• 2) By Syrups: Pediatric Syrups; Adult Syrups; Sugar-Free Syrups
• 3) By Eye Drops: Prescription Eye Drops; Over-the-Counter (OTC) Eye Drops; Combination Eye Drops; Single-Use Eye Drops
• 4) By Other Product Types: Nasal Sprays; Injectable Solutions; Topical Gels or Creams; Suppositories
• Companies Mentioned: Pfizer Inc.; Procter And Gamble Co.; Johnson And Johnson Consumer Inc; Bayer AG; GlaxoSmithKline PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Phenylephrine Drugs Market Characteristics

3. Phenylephrine Drugs Market Trends And Strategies

4. Phenylephrine Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Phenylephrine Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Phenylephrine Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Phenylephrine Drugs Market Growth Rate Analysis
• 5.4. Global Phenylephrine Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Phenylephrine Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Phenylephrine Drugs Total Addressable Market (TAM)

6. Phenylephrine Drugs Market Segmentation

• 6.1. Global Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Syrups
• Eye Drops
• Other Product Types
• 6.2. Global Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cold
• Nasal Decongestion
• Allergic Reaction
• Eye Disease
• Other Indications
• 6.3. Global Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administration
• 6.4. Global Phenylephrine Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Drug Stores And Retail Pharmacies
• Online Pharmacies
• 6.5. Global Phenylephrine Drugs Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate Release Tablets
• Extended Release Tablets
• Combination Tablets
• Orally Disintegrating Tablets
• 6.6. Global Phenylephrine Drugs Market, Sub-Segmentation Of Syrups, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric Syrups
• Adult Syrups
• Sugar-Free Syrups
• 6.7. Global Phenylephrine Drugs Market, Sub-Segmentation Of Eye Drops, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Eye Drops
• Over-the-Counter (OTC) Eye Drops
• Combination Eye Drops
• Single-Use Eye Drops
• 6.8. Global Phenylephrine Drugs Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nasal Sprays
• Injectable Solutions
• Topical Gels Or Creams
• Suppositories

7. Phenylephrine Drugs Market Regional And Country Analysis

• 7.1. Global Phenylephrine Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Phenylephrine Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Phenylephrine Drugs Market

• 8.1. Asia-Pacific Phenylephrine Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Phenylephrine Drugs Market

• 9.1. China Phenylephrine Drugs Market Overview
• 9.2. China Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Phenylephrine Drugs Market

• 10.1. India Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Phenylephrine Drugs Market

• 11.1. Japan Phenylephrine Drugs Market Overview
• 11.2. Japan Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Phenylephrine Drugs Market

• 12.1. Australia Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Phenylephrine Drugs Market

• 13.1. Indonesia Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Phenylephrine Drugs Market

• 14.1. South Korea Phenylephrine Drugs Market Overview
• 14.2. South Korea Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Phenylephrine Drugs Market

• 15.1. Western Europe Phenylephrine Drugs Market Overview
• 15.2. Western Europe Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Phenylephrine Drugs Market

• 16.1. UK Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Phenylephrine Drugs Market

• 17.1. Germany Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Phenylephrine Drugs Market

• 18.1. France Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Phenylephrine Drugs Market

• 19.1. Italy Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Phenylephrine Drugs Market

• 20.1. Spain Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Phenylephrine Drugs Market

• 21.1. Eastern Europe Phenylephrine Drugs Market Overview
• 21.2. Eastern Europe Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Phenylephrine Drugs Market

• 22.1. Russia Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Phenylephrine Drugs Market

• 23.1. North America Phenylephrine Drugs Market Overview
• 23.2. North America Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Phenylephrine Drugs Market

• 24.1. USA Phenylephrine Drugs Market Overview
• 24.2. USA Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Phenylephrine Drugs Market

• 25.1. Canada Phenylephrine Drugs Market Overview
• 25.2. Canada Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Phenylephrine Drugs Market

• 26.1. South America Phenylephrine Drugs Market Overview
• 26.2. South America Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Phenylephrine Drugs Market

• 27.1. Brazil Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Phenylephrine Drugs Market

• 28.1. Middle East Phenylephrine Drugs Market Overview
• 28.2. Middle East Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Phenylephrine Drugs Market

• 29.1. Africa Phenylephrine Drugs Market Overview
• 29.2. Africa Phenylephrine Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Phenylephrine Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Phenylephrine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Phenylephrine Drugs Market Competitive Landscape And Company Profiles

• 30.1. Phenylephrine Drugs Market Competitive Landscape
• 30.2. Phenylephrine Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Procter And Gamble Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson And Johnson Consumer Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis

31. Phenylephrine Drugs Market Other Major And Innovative Companies

• 31.1. Sandoz Group AG
• 31.2. Hikma Pharmaceuticals USA
• 31.3. Siegfried AG
• 31.4. Perrigo Company PLC
• 31.5. Amneal Pharmaceuticals LLC
• 31.6. Civica
• 31.7. Xellia Pharmaceuticals USA LLC
• 31.8. Camber Pharmaceuticals
• 31.9. Exela Pharma Sciences
• 31.10. Eton Pharmaceuticals
• 31.11. SOLA Pharmaceuticals
• 31.12. Fresenius Kabi USA
• 31.13. Somerset Therapeutics
• 31.14. Meitheal Pharmaceuticals
• 31.15. Novadoz Pharmaceuticals LLC

32. Global Phenylephrine Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Phenylephrine Drugs Market

34. Recent Developments In The Phenylephrine Drugs Market

35. Phenylephrine Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Phenylephrine Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Phenylephrine Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Phenylephrine Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer